Fenbendazole 222 mg supplier USA
Febendazole 222 mg is a single-dose, broad-spectrum antiparasitic traditionally used for treating gastrointestinal worm infections such as roundworms, hookworms, whipworms, and pinworms. It’s also under research for potential off-label applications, including cancer-related studies. For use under medical supervision.
Fenbendazole 222 mg tablets is an oral antiparasitic medication used primarily for treating various intestinal worm infections in humans and animals. Fenbendazole 222 mg supplier USA. It falls under the benzimidazole class of anthelmintic drugs, known for effectively eliminating common parasites such as roundworms, hookworms, whipworms, and pinworms.
In addition to its primary role in deworming therapy, Fenbendazole has attracted research interest for its possible anti-cancer properties. Some early-stage studies and anecdotal reports suggest that its ability to disrupt cell metabolism and microtubule function might have implications for slowing the growth of certain tumor cells. Although not FDA-approved for cancer use, it remains under investigation in preclinical settings.
What Is Febendazole 222 mg Used For?
Clinically Approved Use:
- Treatment of gastrointestinal parasitic worms:
- Ascariasis (roundworm)
- Enterobiasis (pinworm)
- Trichuriasis (whipworm)
- Hookworm and threadworm infections
Investigational/Off-Label Use (Under Research):
Studied for possible use as an adjunct in cancer therapy, especially for tumors with glycolytic metabolism
Anecdotal use in integrative protocols for lung, colon, and brain cancer cases
How It Works
Febendazole interferes with microtubules in parasitic cells by binding to beta-tubulin, preventing glucose uptake and energy production in the worm. This ultimately starves and eliminates the parasite.
This same mechanism has been theorized to affect the growth of rapidly dividing abnormal cells, hence the scientific interest in cancer research.
Dosage and Administration
Standard Deworming Dose:
One 222 mg tablet, taken orally
Typically administered as a single dose
Can be taken with or without food
Repeat dose may be required in 10–14 days for persistent infections (per doctor’s guidance)
Cancer-Related Protocols (Experimental Use):
Vary widely and must be supervised by a medical professional
Off-label protocols often include cycling (e.g., 3 days on, 4 days off)—there is no approved dosing standard
Benefits of Febendazole 222 mg
Broad-spectrum antiparasitic activity
Convenient single-dose usage
Safe in adults and children over 2 years (per guidance)
Low cost and widely available
Targets Cancer Cell
Gathering research interest for non-parasitic therapeutic potential
Safety and Precautions
Most users tolerate Febendazole well. Possible side effects include:
Precautions:
Not recommended during early pregnancy
Avoid in patients with known benzimidazole allergy
Use in immunocompromised individuals should be discussed with a doctor
Storage Instructions
Store below 25°C (77°F)
Keep out of direct sunlight
Keep tablets in original packaging and away from moisture
Keep away from pets and children
